Minoryx Therapeutics
Total Raised
$163.1MInvestors Count
22Deal Terms
2Funding, Valuation & Revenue
9 Fundings
Minoryx Therapeutics has raised $163.1M over 9 rounds.
Minoryx Therapeutics's latest funding round was a Grant - II for $29.86M on May 12, 2025.
Minoryx Therapeutics's 2022 revenue was $710.79K. Minoryx Therapeutics's most recent revenue is from 2022.
Sign up for a free demo to see revenue data from 2024, 2022 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/12/2025 | Grant - II | $29.86M | 2 | |||
5/31/2022 | Debt | $710.79K FY 2022 | ||||
5/31/2022 | Series C | |||||
10/21/2020 | Loan | |||||
9/26/2018 | Series B |
Date | 5/12/2025 | 5/31/2022 | 5/31/2022 | 10/21/2020 | 9/26/2018 |
|---|---|---|---|---|---|
Round | Grant - II | Debt | Series C | Loan | Series B |
Amount | $29.86M | ||||
Investors | |||||
Valuation | |||||
Revenue | $710.79K FY 2022 | ||||
Sources | 2 |
Minoryx Therapeutics Deal Terms
2 Deal Terms
Minoryx Therapeutics's deal structure is available for 2 funding rounds, including their Series B from September 26, 2018.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Minoryx Therapeutics Investors
22 Investors
Minoryx Therapeutics has 22 investors. IPCEI invested in Minoryx Therapeutics's Grant - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
5/12/2025 | 5/12/2025 | 1 Grant - II | Government | Germany | ||
4/4/2013 | 5/31/2022 | 4 Seed VC, Series A (2015), Series B (2018), Series C (2022) | Venture Capital | Spain | ||
10/14/2015 | 5/31/2022 | 3 Series A, Series B (2018), Series C (2022) | Venture Capital | Spain | ||
Venture Capital | Belgium | |||||
Government | Spain |
First funding | 5/12/2025 | 4/4/2013 | 10/14/2015 | ||
|---|---|---|---|---|---|
Last Funding | 5/12/2025 | 5/31/2022 | 5/31/2022 | ||
Investor | |||||
Rounds | 1 Grant - II | 4 Seed VC, Series A (2015), Series B (2018), Series C (2022) | 3 Series A, Series B (2018), Series C (2022) | ||
Board Seats | |||||
Type | Government | Venture Capital | Venture Capital | Venture Capital | Government |
Location | Germany | Spain | Spain | Belgium | Spain |
Loading...